 | • レポートコード：GIR-23F3737 • 出版社/出版日：GlobalInfoResearch / 2023年2月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、71ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global African Horse Sickness Vaccines Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界のアフリカ馬疫ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 アフリカ馬疫ワクチン市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・生ワクチン、不活化ワクチン アプリケーション別セグメントは次のように区分されます。 ・馬、ラバ、ロバ 世界のアフリカ馬疫ワクチン市場の主要なマーケットプレーヤーは以下のとおりです。 ・Biopharma、Onderstepoort Biological Products、Veterinary Serum and Vaccine Research Institute 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - アフリカ馬疫ワクチンの概要 - タイプ別分析（2017年vs2021年vs2028年）：生ワクチン、不活化ワクチン - アプリケーション別分析（2017年vs2021年vs2028年）：馬、ラバ、ロバ - 世界のアフリカ馬疫ワクチン市場規模・予測 - 世界のアフリカ馬疫ワクチン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Biopharma、Onderstepoort Biological Products、Veterinary Serum and Vaccine Research Institute ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：生ワクチン、不活化ワクチン ・アプリケーション別分析2017年-2028年：馬、ラバ、ロバ ・アフリカ馬疫ワクチンの北米市場分析 - アフリカ馬疫ワクチンの北米市場：タイプ別市場規模2017年-2028年 - アフリカ馬疫ワクチンの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・アフリカ馬疫ワクチンのヨーロッパ市場分析 - ：アフリカ馬疫ワクチンのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：アフリカ馬疫ワクチンのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・アフリカ馬疫ワクチンのアジア太平洋市場分析 - アフリカ馬疫ワクチンのアジア太平洋市場：タイプ別市場規模2017年-2028年 - アフリカ馬疫ワクチンのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・アフリカ馬疫ワクチンの南米市場分析 - アフリカ馬疫ワクチンの南米市場：タイプ別市場規模2017年-2028年 - アフリカ馬疫ワクチンの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・アフリカ馬疫ワクチンの中東・アフリカ市場分析 - アフリカ馬疫ワクチンの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - アフリカ馬疫ワクチンの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The African Horse Sickness Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global African Horse Sickness Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Horses accounting for % of the African Horse Sickness Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Live Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of African Horse Sickness Vaccines include Biopharma, Onderstepoort Biological Products, Veterinary Serum and Vaccine Research Institute, , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
African Horse Sickness Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Live Vaccines
Killed Vaccines
Market segment by Application can be divided into
Horses
Mules
Donkeys
The key market players for global African Horse Sickness Vaccines market are listed below:
Biopharma
Onderstepoort Biological Products
Veterinary Serum and Vaccine Research Institute
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe African Horse Sickness Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of African Horse Sickness Vaccines, with price, sales, revenue and global market share of African Horse Sickness Vaccines from 2019 to 2022.
Chapter 3, the African Horse Sickness Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the African Horse Sickness Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and African Horse Sickness Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of African Horse Sickness Vaccines.
Chapter 13, 14, and 15, to describe African Horse Sickness Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 African Horse Sickness Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global African Horse Sickness Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global African Horse Sickness Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Horses
1.3.3 Mules
1.3.4 Donkeys
1.4 Global African Horse Sickness Vaccines Market Size & Forecast
1.4.1 Global African Horse Sickness Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global African Horse Sickness Vaccines Sales in Volume (2017-2028)
1.4.3 Global African Horse Sickness Vaccines Price (2017-2028)
1.5 Global African Horse Sickness Vaccines Production Capacity Analysis
1.5.1 Global African Horse Sickness Vaccines Total Production Capacity (2017-2028)
1.5.2 Global African Horse Sickness Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 African Horse Sickness Vaccines Market Drivers
1.6.2 African Horse Sickness Vaccines Market Restraints
1.6.3 African Horse Sickness Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Biopharma
2.1.1 Biopharma Details
2.1.2 Biopharma Major Business
2.1.3 Biopharma African Horse Sickness Vaccines Product and Services
2.1.4 Biopharma African Horse Sickness Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Onderstepoort Biological Products
2.2.1 Onderstepoort Biological Products Details
2.2.2 Onderstepoort Biological Products Major Business
2.2.3 Onderstepoort Biological Products African Horse Sickness Vaccines Product and Services
2.2.4 Onderstepoort Biological Products African Horse Sickness Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Veterinary Serum and Vaccine Research Institute
2.3.1 Veterinary Serum and Vaccine Research Institute Details
2.3.2 Veterinary Serum and Vaccine Research Institute Major Business
2.3.3 Veterinary Serum and Vaccine Research Institute African Horse Sickness Vaccines Product and Services
2.3.4 Veterinary Serum and Vaccine Research Institute African Horse Sickness Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 African Horse Sickness Vaccines Breakdown Data by Manufacturer
3.1 Global African Horse Sickness Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global African Horse Sickness Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in African Horse Sickness Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 African Horse Sickness Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 African Horse Sickness Vaccines Manufacturer Market Share in 2021
3.5 Global African Horse Sickness Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and African Horse Sickness Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global African Horse Sickness Vaccines Market Size by Region
4.1.1 Global African Horse Sickness Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global African Horse Sickness Vaccines Revenue by Region (2017-2028)
4.2 North America African Horse Sickness Vaccines Revenue (2017-2028)
4.3 Europe African Horse Sickness Vaccines Revenue (2017-2028)
4.4 Asia-Pacific African Horse Sickness Vaccines Revenue (2017-2028)
4.5 South America African Horse Sickness Vaccines Revenue (2017-2028)
4.6 Middle East and Africa African Horse Sickness Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global African Horse Sickness Vaccines Sales in Volume by Type (2017-2028)
5.2 Global African Horse Sickness Vaccines Revenue by Type (2017-2028)
5.3 Global African Horse Sickness Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global African Horse Sickness Vaccines Sales in Volume by Application (2017-2028)
6.2 Global African Horse Sickness Vaccines Revenue by Application (2017-2028)
6.3 Global African Horse Sickness Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America African Horse Sickness Vaccines Sales by Type (2017-2028)
7.2 North America African Horse Sickness Vaccines Sales by Application (2017-2028)
7.3 North America African Horse Sickness Vaccines Market Size by Country
7.3.1 North America African Horse Sickness Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America African Horse Sickness Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe African Horse Sickness Vaccines Sales by Type (2017-2028)
8.2 Europe African Horse Sickness Vaccines Sales by Application (2017-2028)
8.3 Europe African Horse Sickness Vaccines Market Size by Country
8.3.1 Europe African Horse Sickness Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe African Horse Sickness Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific African Horse Sickness Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific African Horse Sickness Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific African Horse Sickness Vaccines Market Size by Region
9.3.1 Asia-Pacific African Horse Sickness Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific African Horse Sickness Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America African Horse Sickness Vaccines Sales by Type (2017-2028)
10.2 South America African Horse Sickness Vaccines Sales by Application (2017-2028)
10.3 South America African Horse Sickness Vaccines Market Size by Country
10.3.1 South America African Horse Sickness Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America African Horse Sickness Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa African Horse Sickness Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa African Horse Sickness Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa African Horse Sickness Vaccines Market Size by Country
11.3.1 Middle East & Africa African Horse Sickness Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa African Horse Sickness Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of African Horse Sickness Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of African Horse Sickness Vaccines
12.3 African Horse Sickness Vaccines Production Process
12.4 African Horse Sickness Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 African Horse Sickness Vaccines Typical Distributors
13.3 African Horse Sickness Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global African Horse Sickness Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global African Horse Sickness Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Biopharma Basic Information, Manufacturing Base and Competitors
Table 4. Biopharma Major Business
Table 5. Biopharma African Horse Sickness Vaccines Product and Services
Table 6. Biopharma African Horse Sickness Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Onderstepoort Biological Products Basic Information, Manufacturing Base and Competitors
Table 8. Onderstepoort Biological Products Major Business
Table 9. Onderstepoort Biological Products African Horse Sickness Vaccines Product and Services
Table 10. Onderstepoort Biological Products African Horse Sickness Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Veterinary Serum and Vaccine Research Institute Basic Information, Manufacturing Base and Competitors
Table 12. Veterinary Serum and Vaccine Research Institute Major Business
Table 13. Veterinary Serum and Vaccine Research Institute African Horse Sickness Vaccines Product and Services
Table 14. Veterinary Serum and Vaccine Research Institute African Horse Sickness Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Global African Horse Sickness Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 16. Global African Horse Sickness Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 17. Market Position of Manufacturers in African Horse Sickness Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 18. Global African Horse Sickness Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 19. Head Office and African Horse Sickness Vaccines Production Site of Key Manufacturer
Table 20. African Horse Sickness Vaccines New Entrant and Capacity Expansion Plans
Table 21. African Horse Sickness Vaccines Mergers & Acquisitions in the Past Five Years
Table 22. Global African Horse Sickness Vaccines Sales by Region (2017-2022) & (K Units)
Table 23. Global African Horse Sickness Vaccines Sales by Region (2023-2028) & (K Units)
Table 24. Global African Horse Sickness Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 25. Global African Horse Sickness Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 26. Global African Horse Sickness Vaccines Sales by Type (2017-2022) & (K Units)
Table 27. Global African Horse Sickness Vaccines Sales by Type (2023-2028) & (K Units)
Table 28. Global African Horse Sickness Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 29. Global African Horse Sickness Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 30. Global African Horse Sickness Vaccines Price by Type (2017-2022) & (USD/Unit)
Table 31. Global African Horse Sickness Vaccines Price by Type (2023-2028) & (USD/Unit)
Table 32. Global African Horse Sickness Vaccines Sales by Application (2017-2022) & (K Units)
Table 33. Global African Horse Sickness Vaccines Sales by Application (2023-2028) & (K Units)
Table 34. Global African Horse Sickness Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 35. Global African Horse Sickness Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 36. Global African Horse Sickness Vaccines Price by Application (2017-2022) & (USD/Unit)
Table 37. Global African Horse Sickness Vaccines Price by Application (2023-2028) & (USD/Unit)
Table 38. North America African Horse Sickness Vaccines Sales by Country (2017-2022) & (K Units)
Table 39. North America African Horse Sickness Vaccines Sales by Country (2023-2028) & (K Units)
Table 40. North America African Horse Sickness Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 41. North America African Horse Sickness Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 42. North America African Horse Sickness Vaccines Sales by Type (2017-2022) & (K Units)
Table 43. North America African Horse Sickness Vaccines Sales by Type (2023-2028) & (K Units)
Table 44. North America African Horse Sickness Vaccines Sales by Application (2017-2022) & (K Units)
Table 45. North America African Horse Sickness Vaccines Sales by Application (2023-2028) & (K Units)
Table 46. Europe African Horse Sickness Vaccines Sales by Country (2017-2022) & (K Units)
Table 47. Europe African Horse Sickness Vaccines Sales by Country (2023-2028) & (K Units)
Table 48. Europe African Horse Sickness Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 49. Europe African Horse Sickness Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 50. Europe African Horse Sickness Vaccines Sales by Type (2017-2022) & (K Units)
Table 51. Europe African Horse Sickness Vaccines Sales by Type (2023-2028) & (K Units)
Table 52. Europe African Horse Sickness Vaccines Sales by Application (2017-2022) & (K Units)
Table 53. Europe African Horse Sickness Vaccines Sales by Application (2023-2028) & (K Units)
Table 54. Asia-Pacific African Horse Sickness Vaccines Sales by Region (2017-2022) & (K Units)
Table 55. Asia-Pacific African Horse Sickness Vaccines Sales by Region (2023-2028) & (K Units)
Table 56. Asia-Pacific African Horse Sickness Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 57. Asia-Pacific African Horse Sickness Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 58. Asia-Pacific African Horse Sickness Vaccines Sales by Type (2017-2022) & (K Units)
Table 59. Asia-Pacific African Horse Sickness Vaccines Sales by Type (2023-2028) & (K Units)
Table 60. Asia-Pacific African Horse Sickness Vaccines Sales by Application (2017-2022) & (K Units)
Table 61. Asia-Pacific African Horse Sickness Vaccines Sales by Application (2023-2028) & (K Units)
Table 62. South America African Horse Sickness Vaccines Sales by Country (2017-2022) & (K Units)
Table 63. South America African Horse Sickness Vaccines Sales by Country (2023-2028) & (K Units)
Table 64. South America African Horse Sickness Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 65. South America African Horse Sickness Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 66. South America African Horse Sickness Vaccines Sales by Type (2017-2022) & (K Units)
Table 67. South America African Horse Sickness Vaccines Sales by Type (2023-2028) & (K Units)
Table 68. South America African Horse Sickness Vaccines Sales by Application (2017-2022) & (K Units)
Table 69. South America African Horse Sickness Vaccines Sales by Application (2023-2028) & (K Units)
Table 70. Middle East & Africa African Horse Sickness Vaccines Sales by Region (2017-2022) & (K Units)
Table 71. Middle East & Africa African Horse Sickness Vaccines Sales by Region (2023-2028) & (K Units)
Table 72. Middle East & Africa African Horse Sickness Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 73. Middle East & Africa African Horse Sickness Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 74. Middle East & Africa African Horse Sickness Vaccines Sales by Type (2017-2022) & (K Units)
Table 75. Middle East & Africa African Horse Sickness Vaccines Sales by Type (2023-2028) & (K Units)
Table 76. Middle East & Africa African Horse Sickness Vaccines Sales by Application (2017-2022) & (K Units)
Table 77. Middle East & Africa African Horse Sickness Vaccines Sales by Application (2023-2028) & (K Units)
Table 78. African Horse Sickness Vaccines Raw Material
Table 79. Key Manufacturers of African Horse Sickness Vaccines Raw Materials
Table 80. Direct Channel Pros & Cons
Table 81. Indirect Channel Pros & Cons
Table 82. African Horse Sickness Vaccines Typical Distributors
Table 83. African Horse Sickness Vaccines Typical Customers
List of Figures
Figure 1. African Horse Sickness Vaccines Picture
Figure 2. Global African Horse Sickness Vaccines Revenue Market Share by Type in 2021
Figure 3. Live Vaccines
Figure 4. Killed Vaccines
Figure 5. Global African Horse Sickness Vaccines Revenue Market Share by Application in 2021
Figure 6. Horses
Figure 7. Mules
Figure 8. Donkeys
Figure 9. Global African Horse Sickness Vaccines Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global African Horse Sickness Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global African Horse Sickness Vaccines Sales (2017-2028) & (K Units)
Figure 12. Global African Horse Sickness Vaccines Price (2017-2028) & (USD/Unit)
Figure 13. Global African Horse Sickness Vaccines Production Capacity (2017-2028) & (K Units)
Figure 14. Global African Horse Sickness Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. African Horse Sickness Vaccines Market Drivers
Figure 16. African Horse Sickness Vaccines Market Restraints
Figure 17. African Horse Sickness Vaccines Market Trends
Figure 18. Global African Horse Sickness Vaccines Sales Market Share by Manufacturer in 2021
Figure 19. Global African Horse Sickness Vaccines Revenue Market Share by Manufacturer in 2021
Figure 20. African Horse Sickness Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 African Horse Sickness Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 African Horse Sickness Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 23. Global African Horse Sickness Vaccines Sales Market Share by Region (2017-2028)
Figure 24. Global African Horse Sickness Vaccines Revenue Market Share by Region (2017-2028)
Figure 25. North America African Horse Sickness Vaccines Revenue (2017-2028) & (USD Million)
Figure 26. Europe African Horse Sickness Vaccines Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific African Horse Sickness Vaccines Revenue (2017-2028) & (USD Million)
Figure 28. South America African Horse Sickness Vaccines Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa African Horse Sickness Vaccines Revenue (2017-2028) & (USD Million)
Figure 30. Global African Horse Sickness Vaccines Sales Market Share by Type (2017-2028)
Figure 31. Global African Horse Sickness Vaccines Revenue Market Share by Type (2017-2028)
Figure 32. Global African Horse Sickness Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global African Horse Sickness Vaccines Sales Market Share by Application (2017-2028)
Figure 34. Global African Horse Sickness Vaccines Revenue Market Share by Application (2017-2028)
Figure 35. Global African Horse Sickness Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America African Horse Sickness Vaccines Sales Market Share by Type (2017-2028)
Figure 37. North America African Horse Sickness Vaccines Sales Market Share by Application (2017-2028)
Figure 38. North America African Horse Sickness Vaccines Sales Market Share by Country (2017-2028)
Figure 39. North America African Horse Sickness Vaccines Revenue Market Share by Country (2017-2028)
Figure 40. United States African Horse Sickness Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada African Horse Sickness Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico African Horse Sickness Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe African Horse Sickness Vaccines Sales Market Share by Type (2017-2028)
Figure 44. Europe African Horse Sickness Vaccines Sales Market Share by Application (2017-2028)
Figure 45. Europe African Horse Sickness Vaccines Sales Market Share by Country (2017-2028)
Figure 46. Europe African Horse Sickness Vaccines Revenue Market Share by Country (2017-2028)
Figure 47. Germany African Horse Sickness Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France African Horse Sickness Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom African Horse Sickness Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia African Horse Sickness Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy African Horse Sickness Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific African Horse Sickness Vaccines Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific African Horse Sickness Vaccines Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific African Horse Sickness Vaccines Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific African Horse Sickness Vaccines Revenue Market Share by Region (2017-2028)
Figure 56. China African Horse Sickness Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan African Horse Sickness Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea African Horse Sickness Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India African Horse Sickness Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia African Horse Sickness Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia African Horse Sickness Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America African Horse Sickness Vaccines Sales Market Share by Type (2017-2028)
Figure 63. South America African Horse Sickness Vaccines Sales Market Share by Application (2017-2028)
Figure 64. South America African Horse Sickness Vaccines Sales Market Share by Country (2017-2028)
Figure 65. South America African Horse Sickness Vaccines Revenue Market Share by Country (2017-2028)
Figure 66. Brazil African Horse Sickness Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina African Horse Sickness Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa African Horse Sickness Vaccines Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa African Horse Sickness Vaccines Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa African Horse Sickness Vaccines Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa African Horse Sickness Vaccines Revenue Market Share by Region (2017-2028)
Figure 72. Turkey African Horse Sickness Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt African Horse Sickness Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia African Horse Sickness Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa African Horse Sickness Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of African Horse Sickness Vaccines in 2021
Figure 77. Manufacturing Process Analysis of African Horse Sickness Vaccines
Figure 78. African Horse Sickness Vaccines Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
| 【アフリカ馬疫ワクチンについて】 アフリカ馬疫ワクチンは、主にアフリカ馬疫（AHS）というウイルス性の感染症から馬を守るために開発されたワクチンです。この病気は、特にアフリカ南部や一部のアジア地域で発生し、馬に重篤な症状を引き起こすことがあるため、予防接種が非常に重要です。アフリカ馬疫は、いくつかの異なる型のウイルスによって引き起こされますが、その感染は通常、蚊やその他の昆虫を媒介として行われます。このため、ワクチンの開発は、農業と動物の健康管理において非常に重要な役割を果たしています。 アフリカ馬疫ワクチンの主な特徴としては、まずその安全性があります。ワクチンは、馬に対して少なくとも重篤な副作用を引き起こさないように設計されています。次に、効力も重要です。ワクチンを接種することで、馬はアフリカ馬疫ウイルスに対する免疫応答を生成し、不活化されたウイルスやその一部に触れることなく、感染から保護されます。また、いくつかの型に対する広範な防御が求められるため、マルチバリュー型のワクチンが開発されることもあります。 ワクチンの種類にはいくつかの異なる系統が存在します。一般的に、これらのワクチンは不活化ワクチンまたは生ワクチンの形で提供されます。不活化ワクチンは、ウイルスを高温や化学薬品で不活化させたものであり、体内で免疫応答を引き起こすことができます。一方、生ワクチンは、弱毒化されたウイルスを使用します。これにより、ワクチン接種を受けた馬は、軽度の感染を経験し、これが免疫反応を促進します。生ワクチンは効果が高い一方で、副作用のリスクが伴うため、使用には慎重な判断が求められます。 用途としては、アフリカ馬疫ワクチンは主に競技馬や繁殖馬など、高価な馬に対して使用されます。アフリカ馬疫は致死的な病気であり、馬の健康、競技能力、経済的価値に大きな影響を及ぼすため、予防接種は特に重要です。また、地域や国によっては、法律や規制により特定のワクチン接種が義務付けられることがあります。 アフリカ馬疫に対するワクチンの開発においては、さまざまな関連技術が活用されています。例えば、分子生物学や遺伝子工学の進展によって、ウイルスの遺伝子を解析し、効果的なワクチンの設計が可能になりました。さらに、ワクチンの製造プロセスにおいては、細胞培養技術やトランスジェニック動物の利用が一般的です。これにより、より安全で効果的なワクチンが迅速に供給されるようになっています。 また、ワクチンの効果を評価するためには、臨床試験が不可欠です。これにより、ワクチンの安全性や効果を科学的に証明し、実際の使用に耐えうるものであるかどうかが判断されます。臨床試験は、健康な馬に対して行われ、ワクチン接種後の免疫反応や副作用の発生状況を注意深く観察します。 アフリカ馬疫ワクチンの実施にあたっての課題も存在します。特に、農村地域や資源が限られた地域では、ワクチンの補給や流通が難しく、新たな技術や資源へのアクセスが制限されることがあります。そのため、地域社会への教育や、ワクチン接種に関する啓蒙活動が重要視されています。また、新たなウイルス株の出現や変異にも備え、ワクチンの改良や研究開発が継続的に求められます。 最後に、アフリカ馬疫ワクチンは、馬の健康を守るだけでなく、農業や経済にも大きな影響を与える存在であることを忘れてはいけません。適正なワクチン施用とその普及は、家畜業や競馬産業の持続的な発展にとって不可欠です。したがって、獣医師や関係者、農業従事者が協力し合い、より効果的な予防策を講じていくことが求められます。アフリカ馬疫に対する理解を深めることが、持続可能な開発や動物福祉の向上につながることを願っています。 |
• 日本語訳：アフリカ馬疫ワクチンのグローバル市場2022年
• レポートコード：GIR-23F3737 ▷ お問い合わせ（見積依頼・ご注文・質問）